CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Colinz Laboratories Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Colinz Laboratories Ltd
A/101, Pratik Estate
Mulund Link Road
Phone: +91 2225908002p:+91 2225908002 MUMBAI, 400078  India Ticker: 531210531210

Business Summary
Colinz Laboratories Ltd is an India-based company, which is principally engaged in the manufacturing and marketing of pharmaceutical formulations particularly in gynecological sector. The Company is engaged in manufacturing and marketing various allopathic and Ayurvedic pharmaceutical formulations in the dosage forms of tablets, capsules, liquid orals and ointments. The Company caters the need of gynecologists with specialized products in the treatments of morning sickness, infertility, intrauterine growth restriction (I.U.G.R.) and maintenance of pregnancy. It also offers hematinics and antispasmodics. To physicians/cardiologists, it offers products in the treatment of hypertension, cholesterol, diabetes, piles, pyrexia and malaria. It also offers anti-inflammatory/anti-allergic tablets, capsules and gel; anti fungals; anti acne, and medicated shampoo. The Company's plant is located in Maharashtra.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
YesYes-------

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/20193/31/2019Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board, Managing Director L. S.Mani
Compliance Officer, Non-Executive Independent Director Vasant K.Bhat 42
Whole-Time Director N. K.Menon
Non-Executive Independent Director AttrassaryKrishnakumar 53 1/31/2009

General Information
Outstanding Shares: 4,571,000 (As of 9/30/2019)
Stock Exchange: BOM
Fax Number: +91 2225908006


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 09, 2019